These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33729698)
21. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511 [TBL] [Abstract][Full Text] [Related]
22. Polyethylenimine-mediated synthetic insertion of gold nanoparticles into mesoporous silica nanoparticles for drug loading and biocatalysis. Pandey PC; Pandey G; Narayan RJ Biointerphases; 2017 Mar; 12(1):011005. PubMed ID: 28347142 [TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers. Qu Q; Ma X; Zhao Y Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067 [TBL] [Abstract][Full Text] [Related]
24. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery. Giret S; Wong Chi Man M; Carcel C Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991 [TBL] [Abstract][Full Text] [Related]
26. Silica nanoparticle surface chemistry: An important trait affecting cellular biocompatibility in two and three dimensional culture systems. Hasany M; Taebnia N; Yaghmaei S; Shahbazi MA; Mehrali M; Dolatshahi-Pirouz A; Arpanaei A Colloids Surf B Biointerfaces; 2019 Oct; 182():110353. PubMed ID: 31336281 [TBL] [Abstract][Full Text] [Related]
27. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery. Salve R; Kumar P; Ngamcherdtrakul W; Gajbhiye V; Yantasee W Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112084. PubMed ID: 33947574 [TBL] [Abstract][Full Text] [Related]
28. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. Meng H; Yang S; Li Z; Xia T; Chen J; Ji Z; Zhang H; Wang X; Lin S; Huang C; Zhou ZH; Zink JI; Nel AE ACS Nano; 2011 Jun; 5(6):4434-47. PubMed ID: 21563770 [TBL] [Abstract][Full Text] [Related]
30. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups. Tan SY; Ang CY; Li P; Yap QM; Zhao Y Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108 [TBL] [Abstract][Full Text] [Related]
31. Mesoporous silica nanoparticles in biomedical applications. Li Z; Barnes JC; Bosoy A; Stoddart JF; Zink JI Chem Soc Rev; 2012 Apr; 41(7):2590-605. PubMed ID: 22216418 [TBL] [Abstract][Full Text] [Related]
32. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy. Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application. Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794 [TBL] [Abstract][Full Text] [Related]
34. Electrospun aligned PLGA and PLGA/gelatin nanofibers embedded with silica nanoparticles for tissue engineering. Mehrasa M; Asadollahi MA; Ghaedi K; Salehi H; Arpanaei A Int J Biol Macromol; 2015 Aug; 79():687-95. PubMed ID: 26045092 [TBL] [Abstract][Full Text] [Related]
35. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution. Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804 [TBL] [Abstract][Full Text] [Related]
36. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy. Amin MU; Ali S; Ali MY; Tariq I; Nasrullah U; Pinnapreddy SR; Wölk C; Bakowsky U; Brüßler J Eur J Pharm Biopharm; 2021 Aug; 165():31-40. PubMed ID: 33962002 [TBL] [Abstract][Full Text] [Related]
37. Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer. Wittig R; Rosenholm JM; von Haartman E; Hemming J; Genze F; Bergman L; Simmet T; Lindén M; Sahlgren C Nanomedicine (Lond); 2014 May; 9(7):971-87. PubMed ID: 23898823 [TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of the lemongrass and clove oil encapsulated in mesoporous silica nanoparticles against wheat's take-all disease. Sattary M; Amini J; Hallaj R Pestic Biochem Physiol; 2020 Nov; 170():104696. PubMed ID: 32980050 [TBL] [Abstract][Full Text] [Related]
39. Folate receptor-targeted multimodal fluorescence mesosilica nanoparticles for imaging, delivery palladium complex and in vitro G-quadruplex DNA interaction. Poshteh Shirani M; Rezaei B; Khayamian T; Dinari M; Karami K; Mehri-Lighvan Z; Hosseini Shamili F; Ramazani M; Alibolandi M J Biomol Struct Dyn; 2018 Dec; 36(16):4156-4169. PubMed ID: 29188757 [TBL] [Abstract][Full Text] [Related]